Expert Perspectives on Treating Recurrent Ovarian Cancer

Shannon Westin, MD, analyzes the diagnosis and treatment of a 68-year-old woman with recurrent ovarian cancer.

EP. 1: Analysis of Patient Diagnosis and Treatment

March 26th 2021

Shannon Westin, MD, introduces the case patient and highlights the diagnosis and treatment path to combat stage IV ovarian cancer.

EP. 2: Prognosis of Patients With Ovarian Cancer

March 26th 2021

Shannon Westin, MD, discusses the prognosis of the case patient and the general prognosis and treatment options for ovarian cancer patients overall.

EP. 3: Molecular Testing in Ovarian Cancer

March 26th 2021

Shannon Westin, MD, analyzes the role of molecular testing in newly diagnosed ovarian cancer.

EP. 4: Frontline Treatment Options in Ovarian Cancer

March 26th 2021

Systemic frontline therapy options are explored through the lens of treating ovarian cancer.

EP. 5: Niraparib in the PRIMA Trial

March 26th 2021

Shannon Westin, MD, discusses niraparib and its relation to the design, efficacy, and practical implications of the PRIMA trial.

EP. 6: PARP Inhibitors in Ovarian Cancer Treatment

March 26th 2021

The utilization and effectiveness of using PARP inhibitors in treating ovarian cancer is considered.

EP. 7: Treatment Considerations With Niraparib

March 26th 2021

Shannon Westin, MD, reviews essential treatment considerations for physicians when subscribing niraparib.

EP. 8: Future Treatment of Ovarian Cancer

March 26th 2021

The future of ovarian cancer treatment is discussed through a summary of current treatment options, future directions, and a review the unmet needs facing patients and physicians today.